←Back to Expert Scholars
Translational Medicine / 转化医学Milestone Pediatric Oncology, Combination Chemotherapy
James F. Holland
MD
🏢Mount Sinai Hospital New York🌐USA
Founding Director of Oncology (historical)
85
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
James F. Holland (1925-2018) pioneered combination chemotherapy for acute leukemia in children alongside Emil Frei and Emil Freireich, developing the VAMP regimen. He was a founder of CALGB and received the Lasker Award.
Share:
🧪Research Fields 研究领域
combination chemotherapy
pediatric leukemia
CALGB founder
VAMP regimen
acute leukemia therapy
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 James F. Holland 的研究动态
Follow James F. Holland's research updates
留下邮箱，当我们发布与 James F. Holland（Mount Sinai Hospital New York）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment